SCHEMBL4924596

SCHEMBL4924596

CC(C)Nc1cccc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.45
NPC1 O15118 5/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
PLAU P00749 2/20 0.44
MRGPRX4 Q96LA9 3/20 0.43
PDE5A O76074 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
SENP5 Q96HI0 1/20 0.41
SENP2 Q9HC62 1/20 0.41
SENP1 Q9P0U3 1/20 0.41
ALDH1A1 P00352 3/20 0.41
TP53 P04637 1/20 0.41
ABL1 P00519 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717999 0.95 NPC1 (0.41) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL5119979 0.89 MEN1 (0.50) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL4349556 0.89 THRA (0.52) MEN1KMT2APDE5ASMN1; SMN2HPGD
SCHEMBL4932507 0.89 RAB9A (0.47) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL5113448 0.89 SENP5 (0.52) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL4347509 0.87 THRA (0.57) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL4934497 0.87 HSD17B10 (0.39) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL5718006 0.86 PLAU (0.40) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL4924012 0.86 HSD17B10 (0.38) RAB9ANPC1MEN1KMT2APLAU
SCHEMBL5112743 0.85 SENP1 (0.52) RAB9ANPC1MEN1KMT2APLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA RAB9A 986/4885NPC1 2087/4885MEN1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.